- If AstraZeneca and Gilead Sciences merge, the two could potentially be a formidable force against covid-19.
- India’s vaccine hopes would be aligned with theirs, but we should still boost our own R&D efforts
AstraZeneca, Britain’s largest pharmaceutical company, has reportedly approached the US-based Gilead Sciences for a potential merger. Though the two companies haven’t begun formal negotiations, should they join forces, their output could potentially be at the frontlines of the world’s war against covid-19.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more